Bybit Lowers Barrier to Elite Wealth Management Solutions with Year-End Exclusive for VIP Clients
DUBAI, UAE, Nov. 25, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency,…
Alzheimer’s Association Statement on Oral Semaglutide Phase 3 Topline Data Release
- Results Underscore Need for Continued Research and Diverse Treatment PipelineCHICAGO, Nov.…
Bitget Slashes Stock Futures Trading Fees by 90% as Daily Volume Surpasses $300 Million
VICTORIA, Seychelles, Nov. 7, 2025 /PRNewswire/ -- Bitget, the world's largest Universal…
Picarro Launches the P-Cubed Mobile App, Putting Smarter Natural Gas Leak Investigations in Field Technicians’ Hands
SANTA CLARA, Calif., Oct. 28, 2025 /PRNewswire/ -- Picarro, Inc., a global…
Flexsys Earns EcoVadis Platinum Rating and Validates Ambitious Science-Based Targets, Reinforcing Its Commitment to a Net-Zero, Sustainable Tire Industry
Milestones affirm Flexsys' leadership in sustainability, from top 1% recognition to credible near-term…
Full product line of TrinaTracker Vanguard series now Carbon Footprint certified
CHANGZHOU, China, Oct. 2, 2025 /PRNewswire/ -- TrinaTracker, a provider of smart…
NEXEN TIRE Secures SBTi Approval for Greenhouse Gas Reduction Targets
Committed to reducing direct and indirect greenhouse gas emissions through systematic and…
Nacuity Pharmaceuticals Announces Positive Data from Clinical Trial Evaluating NPI-001 to Treat Retinitis Pigmentosa Associated with Usher Syndrome
September 11, 2025 09:00 ET | Source: Nacuity Pharmaceuticals, Inc. NPI-001 shows…
Netcore Cloud Report Reveals: AI Personalisation Accelerates Festive Ecommerce Growth by 40-60% for Leading Brands
New Insightful report details how AI-powered strategies, not just discounts, are driving…
Novo Nordisks Wegovy cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular diseas
Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater…